The CD44 + CD24 + ESA + phenotype exhibited a 100-fold increase in tumor-initiating capacity versus non-tumorigenic cancer cells, gauged from a very little number of sorted cells required to produce tumors histologically similar to primary PC in immunocompromised mice. Here, CD44 is linked to cancer.